公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study | Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; You S.-L.; Wang L.-Y.; Wang C.-H.; WEI J. CHEN ; Chen C.-J.; CHANG-YAO HSIEH ; Lee, Hsuan-Shu ; PEI-MING YANG ; CHIEN-HUNG CHEN ; Chen J.D.; Huang S.P.; CHYI-FENG JAN ; HSIU-HSI CHEN ; Sun C.A.; Wu M.H.; Chen S.Y.; Chu K.E.; Ho S.C.; Lu T.G.; Wu W.P.; Ou T.Y.; Lin C.G.; Shih K.C.; Chung W.S.; Li C.; Chen C.C.; How W.C. | Journal of Infectious Diseases | 448 | 418 | |
2013 | Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy | Chang K.-C.; Wu Y.-Y.; Hung C.-H.; Lu S.-N.; Lee C.-M.; Chiu K.-W.; Tsai M.-C.; Tseng P.-L.; Huang C.-M.; Cho C.-L.; Chen, Tony Hsiu Hsi ; Hu T.-H. | British Journal of Cancer | 54 | 50 | |
2011 | Community and personal risk factors for hepatitis C virus infection: A survey of 23 820 residents in Taiwan in 1991-2 | Lee M.-H.; Yang H.-I.; Jen C.-L.; Lu S.-N.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; You S.-L.; Sun C.-A.; Wang L.-Y.; WEI J. CHEN ; Chen C.-J.; R.E.V.E.A.L.-HCV Study Group; (CHYI-FENG JAN) | Gut | 49 | 50 | |
2008 | Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults | Lu S.-N.; Wang J.-H.; Chen P.-F.; Tung H.-D.; Tseng P.-L.; Hung C.-H.; Kee K.-M.; Chen C.-H.; Chang K.-C.; Lee C.-M.; Changchien C.-S.; Chen Y.-D.; Tsai L.-S.; Chen, Tony Hsiu Hsi | Cancer Epidemiology Biomarkers and Prevention | 20 | 19 | |
2018 | Current efficacy and prospectives of oral direct-acting antiviral drugs to treat chronic hepatitis c | Lo C.-C.; Chen M.-T.; Huang K.-C.; Lin C.-H.; Cheng H.-S.; Liao Y.-T.; Hung L.-W.; Lu S.-N.; CHIEN-HUNG CHEN | Journal of Internal Medicine of Taiwan | 0 | 0 | |
2014 | Distinct seromarkers predict different milestones of chronic hepatitis B progression | Liu J.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; CHUHSING KATE HSIAO ; Chen C.-J. | Hepatology | 25 | 21 | |
2006 | Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients | CHIEN-HUNG CHEN ; Chang T.-T.; Cheng K.-S.; Su W.-W.; Yang S.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Liver International | 63 | 56 | |
2014 | Erratum: Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia (Journal of Hepatology (2013) 59 (1073-1080)) | Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN ; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J. | Journal of Hepatology | 0 | 0 | |
2007 | Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: Geographic variations among 502 villages in southern Taiwan | Tsai M.-C.; Kee K.-M.; Chen Y.-D.; Lin L.-C.; Tsai L.-S.; Chen, Tony Hsiu Hsi ; Lu S.-N. | Journal of Gastroenterology and Hepatology (Australia) | 65 | 60 | |
2015 | Geographic Variation of Chronic Kidney Disease Prevalence: Correlation with the Incidence of Renal Cell Carcinoma or Urothelial Carcinoma? | Yap Y.-S.; Chuang K.-W.; CHUN-JU CHIANG ; Chuang H.-Y.; Lu S.-N. | BioMed Research International | 1 | 1 | |
2009 | Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: Identification of potential high HCV endemic areas | Su W.-W.; CHIEN-HUNG CHEN ; Lin H.H.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Wu J.-C.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Hepatology International | 13 | 10 | |
2010 | HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Infectious Diseases | 42 | 37 | |
2002 | Hepatitis B e antigen and the risk of hepatocellular carcinoma | Yang H.-I.; Lu S.-N.; Liaw Y.-F.; You S.-L.; Sun C.-A.; Wang L.-Y.; CHUHSING KATE HSIAO ; PEI-JER CHEN ; Chen D.-S.; Chen C.-J. | New England Journal of Medicine | 1090 | 938 | |
2017 | Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study | TAI-SHUAN LAI ; Lee M.-H.; Yang H.-I.; You S.-L.; Lu S.-N.; Wang L.-Y.; Yuan Y.; L'Italien G.; KUO-LIONG CHIEN ; Chen C.-J.; the REVEAL-HCV Study Group | Hepatology | 57 | 52 | |
2020 | Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan | Wang J.-H.; CHIEN-HUNG CHEN ; Chang C.-M.; Feng W.-C.; Lee C.-Y.; Lu S.-N. | Journal of the Formosan Medical Association | 13 | 10 | |
2010 | Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study | Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; PEI-JER CHEN ; You S.-L.; Wang L.-Y.; WEI J. CHEN ; Chen C.-J. | Journal of Clinical Oncology | 143 | 131 | |
2017 | High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease | TAI-SHUAN LAI ; Lee M.-H.; Yang H.-I.; You S.-L.; Lu S.-N.; Wang L.-Y.; Yuan Y.; L'Italien G.; KUO-LIONG CHIEN ; Chen C.-J.; REVEAL-HCV Study Group | Kidney International | 27 | 26 | |
2021 | How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers? | Chen M.-H.; Lu S.-N.; CHIEN-HUNG CHEN ; Lin P.-C.; Jiang J.-K.; D’yachkova Y.; Lukanowski M.; Cheng R.; Chen L.-T. | Cancers | 2 | 1 | |
2009 | Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation | Chiang J.-C.; Lin C.-Y.; Wang J.-H.; Kee K.-M.; Chen P.-F.; Chen Y.-D.; Tsai L.-S.; Chen, Tony Hsiu Hsi ; Lu S.-N. | Transactions of the Royal Society of Tropical Medicine and Hygiene | 4 | 3 | |
2019 | Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients | Hu H.-H.; Liu J.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Quan Y.; Xia N.-S.; Chen C.-J.; PEI-JER CHEN ; Yang H.-I. | Clinical Gastroenterology and Hepatology | 20 | 17 |